Placental Transfer of Succinylcholine Causing Transient Respiratory Depression in the Newborn
On March 26, 1986, a 34-year-old (163 cm171 kg) multigravida underwent caesarean section under general anaesthesia for oblique lie of the foetus. The patient, in good health, was at term of an uneventful pregnancy. She had had no previous surgery or anaesthesia. She was not on any medication and there was no history of exposure to organophosphates.
Uterine contractions started the previous evening. She had episodes of variable decelerations that were treated with change of position and oxygen supplementation.
After breathing 100% oxygen for five minutes, rapid sequence anaesthesia was induced with thiamylal 200 mg and succinylcholine (Sch) 100 mg IV and maintained with 02:NP (3:3) and halothane 0.5%. After delivery of the baby, halothane was discontinued and butorphanol 2 mg IV given. Cefazolin 2g were administered IV. A neuromuscular blockade stimulator (Neurostim 11) showed no response during the entire procedure. No supplemental muscle relaxant was given.
The baby was delivered within three minutes of Sch administration. Onset of respiration and development of acceptable regular respiratory pattern were slightly delayed. The cry was weak. Apgar scores of 5 and 8 were noted at 1 and 5 minu!es respectively. Clinical improvement in colour, breathing and reflex activity was achieved by stimulation and 'bagging with Ambu bag'. No other intervention was necessary.
At the end of the procedure the mother's respiration had not returned. It was necessary to mechanically ventilate for four hours before spontaneous muscular activity and respiration returned. Approximately two hours after induction, a weak response to twitch and tetanic stimulation was noted. After another two hours she could open her eyes and showed signs of regaining muscle strength. An hour later she was extubated. During this period serum electrolytes and arterial blood gases were normal.
Blood for enzyme studies was drawn from the mother and the baby on the day of the delivery and the first post partum day respectively. No cord blood was drawn for enzyme analysis. The pseudocholinesterase (ChE) activity was measured by determining total enzyme content and dibucaine number (DN). While total enzyme content is a quantitative measure, DN is a qualitative estimate of enzyme activity. ChE in the mother was extremely low preventing DN determination. * The newborn infant had ChE level of 410 unitsllitre (normal 2436-4872 U/l) and DN 21.* Three months later blood for enzyme evaluation was taken from the entire family including mother and baby. The results are shown in Table 1 Normally, ChE enzymatically hydrolyses Sch, such that only 10-15% of an intravenously administered Sch reaches the neuromuscular junction. I However, in the presence of abnormal ChE activity, Sch remains in the body for much longer time resulting in prolonged muscle weakness and paralysis. This is clinically important because these lead to apnoea and respiratory depression requiring prolonged mechanical ventilation.
Sch crosses the placenta freely which usually is innocuous in the presence of normal ChE activity.2 However, with abnormal ChE various degrees of muscle weakness and paralysis may result in apnoea in the newborn. 3 It is noteworthy that whereas on the delivery day the mother's enzyme values were too low to measure, by the third month the enzyme values were 490 VII and the DN 24%. This is consistent with the known depression of ChE activity during the last trimester of pregnancy and emphasises the point that even atypical ChE is depressed.
After looking at the results of the initial laboratory studies done on the mother and infant, we expected the father to be atypical homozygous or heterozygous to ChE. But the Four allelic genes are recognised to account for different types of plasma cholinesterase. El U -the normal gene, El' -the atypical or dibucaine-resistant gene, El' -the silent gene and Elf -the fluoride-resistant gene. 5 These four genes give rise to ten recognised genotypes, which in turn form seven different phenotypes ( Table 2) .
Based on the data from Table 1 , we propose that the mother is atypical homozygous El' El' and the father heterozygous Elu El' (Figure 1) . The six children with low ChE activity are heterozygous El' El' and the exceptional child Elu El'. These data would agree with the phenotypic presentation of such a genotypic population as described by Whitaker 5 (Table  3 ). The mother (A -El' El') and the six children (A -El' El') have the same phenotypic presentation but differ in the genotypic makeup.
ChE activity is lower in term pregnancy patients and in the post partum period. 6 In patients with normal ChE this decrease is clinically insignificant because of the increased volume of distribution of Sch. 7
In the three months since birth the baby's enzyme activity increased from 410 U 11 to 910 U/l while the DN remained at the 20-21% 
